iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Profitability This table compares iTeos Therapeutics and […]
Caribou Biosciences (NASDAQ:CRBU – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, dividends, valuation and analyst recommendations. Earnings and Valuation This table compares Caribou […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities researchers at HC Wainwright boosted their Q1 2024 earnings estimates for shares of iTeos Therapeutics in a research report issued on Thursday, March 7th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($1.22) per share for the quarter, up from their prior […]
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.03) by $0.18, MarketWatch Earnings reports. iTeos Therapeutics Trading Up 7.0 % Shares of ITOS stock opened at $12.39 on Friday. iTeos Therapeutics has a fifty-two […]
Deerfield Management Company L.P. Series C Makes New Investment in iTeos Therapeutics, Inc. (NASDAQ:ITOS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.